GLAXO.NSE · GlaxoSmithKline Pharmaceuticals Limited
-
-
| ISIN | INE159A01016 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers-General |
| CurrencyCode | INR |
| Exchange | NSE |
| Beta | 0.1 |
|---|---|
| Dividend Yield | 2.4% |
| Target Price | 1352 |
| PE Ratio | 50.66 |
| Market Cap | 213B |
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
Learn More